← Back to Clinical Trials
Recruiting NCT06704958

NCT06704958 Augmented Momentary Personal Ecological Risk Evaluation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06704958
Status Recruiting
Phase
Sponsor University of Washington
Condition Suicidal Ideation
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-09-25
Primary Completion 2026-06-01

Trial Parameters

Condition Suicidal Ideation
Sponsor University of Washington
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 16 Years
Max Age 30 Years
Start Date 2025-09-25
Completion 2026-06-01
Interventions
AMPERE EMA app

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this intervention study is to co-design and test an Ecological Momentary Assessment (EMA) prototype tool with young adults aged 16-30 experiencing suicidality to see if it is an acceptable and usable clinical tool for risk management. The main study aims are: * To co-design a prototype EMA suicide risk monitoring system with patients and health care provider input using Human Centered Design (HCD) methods. * To test the developed EMA protype with providers and their young adult patients aged 16-30 experiencing suicidality to determine if the EMA prototype is an acceptable and usable clinical tool. Young adult participants receiving care for active suicidal ideation will * Download and use the EMA prototype for a total of two months. * Complete 3 online surveys at 0, 1 and 2 months after enrolled in the study.

Eligibility Criteria

Inclusion Criteria: * Young adults (age 16-30 years) * Receiving care at University of Washington Primary Care for suicidal ideation as determined by Electronic Health Record problem list or PHQ-9 suicide risk item \>0 in previous year and/or recent (past year) history of suicide attempt and/or active suicidal ideation. * Ability to consent to participate Exclusion Criteria: * Age \<16 or \>30, * Non-English speaking * No smart phone access * Any clinical medical/psychiatric condition, severity of that condition, or life situation that would compromise safe and voluntary study participation.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology